CIK 0000842023 · Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411427402
- Phone
- 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-11-30 | Furlow Brenda S. SVP - General Counsel | Option exercise · Stock Option (Right to Buy) | −938 | 13,538 | ||
| 2020-11-30 | Furlow Brenda S. SVP - General Counsel | Option exercise · Stock Option (Right to Buy) | −10,857 | 0 | ||
| 2020-11-18 | BAUMGARTNER ROBERT V Director | Option exercise | +5,000 | $66.90 | $335K | 14,612 |
| 2020-11-18 | BAUMGARTNER ROBERT V Director | Sale | −5,000 | $303.34 | $1.5M | 9,612 |
| 2020-11-18 | BAUMGARTNER ROBERT V Director | Option exercise · Stock Options (right to buy) | −5,000 | 0 | ||
| 2020-11-11 | Hippel James Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −7,391 | 59,942 | ||
| 2020-11-11 | Hippel James Chief Financial Officer | Option exercise | +7,391 | $106.59 | $788K | 16,528 |
| 2020-11-11 | Hippel James Chief Financial Officer | Sale | −6,291 | $306.93 | $1.9M | 10,237 |
| 2020-11-11 | Hippel James Chief Financial Officer | Sale | −1,100 | $307.78 | $339K | 9,137 |
| 2020-11-11 | Hippel James Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −9,137 | 58,196 | ||
| 2020-11-09 | Seth Alpna Director | Option exercise | +1,898 | $179.84 | $341K | 4,037 |
| 2020-11-09 | Seth Alpna Director | Option exercise | +3,125 | $125.05 | $391K | 7,162 |
| 2020-11-09 | Seth Alpna Director | Sale | −1,358 | $305.74 | $415K | 5,804 |
| 2020-11-09 | Seth Alpna Director | Sale | −3,665 | $306.95 | $1.1M | 2,139 |
| 2020-11-09 | Seth Alpna Director | Option exercise · Stock Option (Right to Buy) | −1,898 | 0 | ||
| 2020-11-09 | Seth Alpna Director | Option exercise · Stock Option (Right to Buy) | −3,125 | 0 | ||
| 2020-11-09 | Hippel James Chief Financial Officer | Option exercise | +3,600 | $106.59 | $384K | 12,737 |
| 2020-11-09 | Hippel James Chief Financial Officer | Sale | −1,100 | $306.81 | $337K | 11,637 |
| 2020-11-09 | Hippel James Chief Financial Officer | Sale | −100 | $307.74 | $31K | 11,537 |
| 2020-11-09 | Hippel James Chief Financial Officer | Sale | −1,098 | $310.55 | $341K | 10,439 |
Page 37 of 53 · 1,043 trades